Invention Grant
US09242933B2 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)
有权
杂环化合物作为代谢型谷氨酸受体2（mGlu2受体）的阳性调节剂
- Patent Title: Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)
- Patent Title (中): 杂环化合物作为代谢型谷氨酸受体2（mGlu2受体）的阳性调节剂
-
Application No.: US12126174Application Date: 2008-05-23
-
Publication No.: US09242933B2Publication Date: 2016-01-26
- Inventor: Herve Geneste , Daryl Sauer , Wilfried Braje , Wilhelm Amberg , Mario Mezler , Margaretha Henrica Maria Bakker
- Applicant: Herve Geneste , Daryl Sauer , Wilfried Braje , Wilhelm Amberg , Mario Mezler , Margaretha Henrica Maria Bakker
- Applicant Address: DE Wiesbaden
- Assignee: AbbVie Deutschland GmbH & Co. KG
- Current Assignee: AbbVie Deutschland GmbH & Co. KG
- Current Assignee Address: DE Wiesbaden
- Agency: Michael Best & Friedrich LLP
- Agent Lisa V. Mueller
- Main IPC: C07D207/335
- IPC: C07D207/335 ; C07D409/06 ; C07D215/12 ; C07D231/12 ; A61K31/44 ; C07D209/14 ; C07D209/26 ; C07D213/36 ; C07D213/38 ; C07D233/58 ; C07D239/26 ; C07D261/08 ; C07D277/28 ; C07D307/14 ; C07D307/54 ; C07D333/20 ; C07D333/58 ; C07D407/04 ; C07D409/04
Abstract:
The present invention relates to heterocyclic compounds which are positive modulators of metabotropic glutamate receptor. The present invention also relates to the use of these compounds for preparing a pharmaceutical composition and to a method of treating a medical disorder, selected from neurological and psychiatric disorders associated with glutamate dysfunction.
Public/Granted literature
- US20080300260A1 HETEROCYCLIC COMPOUNDS AS POSITIVE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 (MGLU2 receptor) Public/Granted day:2008-12-04
Information query
